Business Intelligence

Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.

Medtronic’s diabetes spin-off files for IPO
Make way for MiniMed! Medtronic's diabetes division has filed the necessary paperwork to go public. The company hopes to be traded on Nasdaq under the symbol MMED.
Cencora to buy nationwide oncology network in $5B deal
The Pennsylvania-based drug distributor announced it would be buying OneOncology, a physician-led specialty service group in which it already owned a minority stake. The company said the acquisition will complement its "pharmaceutical-centric strategy."
More interventional procedures may be coming to an ambulatory surgical center near you
ASCs have their limitations, but they are also associated with several benefits for cardiologists and patients alike.
Texas sues Epic for allegedly ‘gatekeeping’ children’s medical records
Paxton says the “woke” EHR giant is intentionally making it harder for patients and families to access historical medical data, violating state law. Epic denies the allegation.
Mark Cuban, Humana CEO announce drug pricing partnership during Forbes panel
Mark Cuban's startup Cost Plus Drugs and insurer Humana are said to be working on a deal that would allow Medicare Advantage patients to buy drugs directly from manufacturers. The terms of the agreement—which Forbes reports is in its early stages—are still unknown.

How the Mark Cuban prescription drug playbook could save taxpayers billions

A new analysis reveals that insurers could put between $228 million and $2.15 billion back in taxpayers’ pockets by purchasing a series of generic oncology medications at the same prices obtained by the Mark Cuban Cost Plus Drug Company.

Industry Watcher’s Digest

Buzzworthy developments of the past few days.

Merck Januvia Janumet Steglujan Nitroso-STG-19 (NTTP) type 2 diabetes

Merck sues US government over Medicare's drug price negotiation liberties, calls program a 'sham'

Merck believes the Inflation Reduction Act-launched effort “coerces” manufacturers to enter into agreements to sell their top products at a fraction of their actual value.

Fortune 500's top 10 healthcare companies

A total of 80 healthcare companies are among those that brought in the most revenue for the fiscal year, according to the magazine's most recent rankings.

Industry Watcher’s Digest

Buzzworthy developments of the past few days.

87% of mammography centers now have 3D breast imaging systems

Rapid adoption of digital breast tomosynthesis has increasingly made it a new standard of care.

Layoffs up 287% in first 5 months of 2023; healthcare sector not immune

Healthcare companies, including manufacturers that produce health products, announced a total of 33,085 layoffs in the first five months of 2023—an 81% increase compared to the same time frame in 2022.

Industry Watcher’s Digest

Buzzworthy developments of the past few days.

Business Intelligence

Medtronic’s diabetes spin-off files for IPO

Cencora to buy nationwide oncology network in $5B deal

More interventional procedures may be coming to an ambulatory surgical center near you

Texas sues Epic for allegedly ‘gatekeeping’ children’s medical records

Mark Cuban, Humana CEO announce drug pricing partnership during Forbes panel